Ditchcarbon
  • Contact
  1. Organizations
  2. Cogstate Limited
Public Profile
Pharmaceutical Preparation Manufacturing
AU
updated 3 months ago

Cogstate Limited Sustainability Profile

Company website

Cogstate Limited, headquartered in Australia, is a leading player in the cognitive assessment industry, specialising in innovative digital solutions for brain health. Founded in 1999, the company has made significant strides in developing unique cognitive testing tools that are widely used in clinical trials and healthcare settings. With a focus on enhancing the accuracy and efficiency of cognitive assessments, Cogstate offers a suite of products that leverage advanced technology to deliver reliable results. Their proprietary platform is designed to streamline the evaluation of cognitive function, making it a preferred choice among researchers and clinicians alike. Recognised for its commitment to improving mental health outcomes, Cogstate has established a strong market position, serving clients across North America, Europe, and Asia. The company continues to set benchmarks in the industry, contributing to advancements in neuropsychological research and patient care.

DitchCarbon Score

How does Cogstate Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

14

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Cogstate Limited's score of 14 is lower than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.

8%

Let us know if this data was useful to you

Cogstate Limited's reported carbon emissions

As of the latest available data, Cogstate Limited has not disclosed specific carbon emissions figures for the years 2019, 2018, or 2017. The company does not report on Scope 1, Scope 2, or Scope 3 emissions, indicating a lack of detailed emissions data. Cogstate Limited has not set any documented reduction targets or commitments to the Science Based Targets initiative (SBTi), nor have they made any climate pledges. This absence of formal commitments suggests that the company may be in the early stages of developing a comprehensive climate strategy. The carbon intensity of their share investments has been noted, with values of approximately 0.989 kg CO2e per AUD in 2019, and about 0.001 kg CO2e per AUD in both 2018 and 2017. However, these figures do not provide a complete picture of the company's overall carbon footprint. In summary, while Cogstate Limited has some data related to carbon intensity, it lacks comprehensive emissions reporting and formal climate commitments, which are essential for understanding its impact on climate change and its role in the broader industry context.

How Carbon Intensive is Cogstate Limited's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Cogstate Limited's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Cogstate Limited's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Cogstate Limited is in AU, which has a very high grid carbon intensity relative to other regions.

Cogstate Limited's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Cogstate Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Cogstate Limited's Emissions with Industry Peers

Eisai

JP
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Eli Lilly and Company

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 15 hours ago

Amgen

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Roche Holding AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Sage Therapeutics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 30 days ago

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251104.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy